Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

W F Rigby, T Stacy, M W Fanger, W F Rigby, T Stacy, M W Fanger

Abstract

Recent studies have suggested that vitamin D may have other important biologic activities in addition to its well-characterized role in the maintenance of calcium homeostasis. Discovery of cytosolic receptors for vitamin D in human peripheral blood monocytes and lectin-stimulated lymphocytes prompted us to study the effects of 1,25-dihydroxyvitamin D3 (calcitriol), the most biologically active metabolite of vitamin D, upon phytohemagglutinin (PHA)-induced lymphocyte blast transformation. We have found that calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Furthermore, calcitriol suppressed interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. Lastly, the suppressive effect of calcitriol on cellular proliferation was partially reversed by the addition of saturating amounts of purified IL-2. We conclude that calcitriol is a potent inhibitor of PHA-induced lymphocyte blast transformation and that this effect is mediated, in part, through suppression of IL-2 production. Thus, calcitriol appears to possess immunoregulatory properties that have been unappreciated heretofore.

References

    1. Int J Cancer. 1976 May 15;17(5):565-77
    1. Eur J Immunol. 1975 Apr;5(4):259-62
    1. J Immunol. 1978 Jun;120(6):2027-32
    1. J Immunol. 1979 Oct;123(4):1624-31
    1. Ann Intern Med. 1980 Mar;92(3):406-16
    1. Biochem Biophys Res Commun. 1980 Jul 31;95(2):596-602
    1. Immunol Rev. 1980;51:337-57
    1. J Exp Med. 1981 Nov 1;154(5):1455-74
    1. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990-4
    1. Biochem Biophys Res Commun. 1981 Oct 15;102(3):937-43
    1. Endocr Rev. 1982 Fall;3(4):331-66
    1. Proc Natl Acad Sci U S A. 1983 Jan;80(1):201-4
    1. Science. 1983 Sep 16;221(4616):1181-3
    1. J Immunol. 1983 Oct;131(4):1808-15
    1. J Clin Endocrinol Metab. 1983 Dec;57(6):1308-10
    1. J Clin Invest. 1983 Nov;72(5):1856-60
    1. J Clin Invest. 1984 Mar;73(3):731-9

Source: PubMed

3
Abonnere